Nasdaq Helsinki listed ophthalmic diagnostic solutions vendor Revenio has bought Australian teleophthalmology and clinical communication platform Oculo, heralding a move into the eye health software sector for the Finnish company.

Oculo was founded in 2015 as a spin-out from the Centre for Eye Research Australia (CERA) to support the sharing of clinical imaging, referrals and other clinical correspondence securely between healthcare professionals.